Left atrial appendage exclusion for stroke prevention in atrial fibrillation

Cardiology Research and Practice

Volumn 1, Issue 1, 2012, Pages

  Patel, Taral K ^a   Yancy, Clyde W ^a   Knight, Bradley P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APIXABAN; DABIGATRAN; NITINOL; POLYETHYLENE; RIVAROXABAN; WARFARIN;

BLEEDING DISORDER; CARDIOEMBOLIC STROKE; COST EFFECTIVENESS ANALYSIS; DEVICE REMOVAL; DISEASE ASSOCIATION; DRUG COST; DRUG DELIVERY SYSTEM; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM APPENDAGE EXCLUSION; HEART SURGERY; HUMAN; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84869040269     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.1155/2012/610827     Document Type: Review

References (39)

1. Go A. S., Hylek E. M., Phillips K. A., Chang Y. C., Henault L. E., Selby J. V., Singer D. E., Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. The Journal of the American Medical Association 2001 285 18 2370 2375 2-s2.0-0035832261 (Pubitemid 32424106)
2. Wazni O., Wilkoff B., Saliba W., Catheter ablation for atrial fibrillation. The New England Journal of Medicine 2011 365 2296 2304 10.1056/NEJMct1109977
3. Feinberg W. M., Blackshear J. L., Laupacis A., Kronmal R., Hart R. G., Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Archives of Internal Medicine 1995 155 5 469 473 2-s2.0-0028921708
4. Miyasaka Y., Barnes M. E., Gersh B. J., Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006 114 11 119 125 2-s2.0-33748676104 10.1161/CIRCULATIONAHA.106.178309 (Pubitemid 44386473)
5. Roger V. L., Go A. S., Lloyd-Jones D. M., Heart disease and stroke statistics-2012 update: a report from the American heart association. Circulation 2012 125 1 e2-e220
6. Lip G. Y. H., Blann A. D., Atrial fibrillation and abnormalities of hemostatic factors. American Journal of Cardiology 2001 87 9 1136 1137 2-s2.0-0035328193 10.1016/S0002-9149(01)01546-6 (Pubitemid 32710339)
7. Chung M. K., Martin D. O., Sprecher D., Wazni O., Kanderian A., Carnes C. A., Bauer J. A., Tchou P. J., Niebauer M. J., Natale A., Van Wagoner D. R., C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001 104 24 2886 2891 2-s2.0-0035846667 (Pubitemid 33139098)
8. Guazzi M., Arena R., Endothelial dysfunction and pathophysiological correlates in atrial fibrillation. Heart 2009 95 2 102 106 2-s2.0-61449176167 10.1136/hrt.2007.135277
9. Blackshear J. L., Odell J. A., Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Annals of Thoracic Surgery 1996 61 2 755 759 2-s2.0-0030051404 10.1016/0003-4975(95)00887-X (Pubitemid 26060923)
10. Johnson W. D., Ganjoo A. K., Stone C. D., The left atrial appendage: our most lethal human attachment! surgical implications. European Journal Cardio-Thoracic Surgery 2000 17 6 718 722 10.1016/S1010-7940(00)00419-X (Pubitemid 30364952)
11. Veinot J. P., Harrity P. J., Gentile F., Khandheria B. K., Bailey K. R., Eickholt J. T., Seward J. B., Tajik A. J., Edwards W. D., Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation 1997 96 9 3112 3115 2-s2.0-0030723977 (Pubitemid 27500115)
12. Beinart R., Heist E. K., Newell J. B., Holmvang G., Ruskin J. N., Mansour M., Left atrial appendage dimensions predict the risk of stroke/TIA in patients with atrial fibrillation. Journal of Cardiovascular Electrophysiology 2011 22 1 10 15 2-s2.0-78751471540 10.1111/j.1540-8167.2010.01854.x
13. Fuster V., Rydén L. E., Cannom D. S., Crijns H. J., Curtis A. B., Ellenbogen K. A., Halperin J. L., Kay G. N., Le Huezey J. Y., Lowe J. E., Olsson S. B., Prystowsky E. N., Tamargo J. L., Wann L. S., 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2011 123 10 e269 e367 2-s2.0-79953038399 10.1161/CIR.0b013e318214876d
14. Gage B. F., Waterman A. D., Shannon W., Boechler M., Rich M. W., Radford M. J., Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation. The Journal of the American Medical Association 2001 285 22 2864 2870 2-s2.0-0035854054 (Pubitemid 32537350)
15. Lip G. Y. H., Nieuwlaat R., Pisters R., Lane D. A., Crijns H. J. G. M., Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010 137 2 263 272 2-s2.0-76749163232 10.1378/chest.09-1584
16. Hart R. G., Pearce L. A., Aguilar M. I., Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine 2007 146 12 857 867 2-s2.0-34347394385 (Pubitemid 351650486)
17. Sudlow M., Thomson R., Thwaites B., Rodgers H., Kenny R. A., Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. The Lancet 1998 352 9135 1167 1171 2-s2.0-0032505605 10.1016/S0140-6736(98)01401-9 (Pubitemid 28458530)
18. Brass L. M., Krumholz H. M., Scinto J. M., Radford M., Warfarin use among patients with atrial fibrillation. Stroke 1997 28 12 2382 2389 2-s2.0-0031470274 (Pubitemid 28007636)
19. Go A. S., Hylek E. M., Borowsky L. H., Phillips K. A., Selby J. V., Singer D. E., Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Annals of Internal Medicine 1999 131 12 927 934 2-s2.0-0033593072 (Pubitemid 30005032)
20. Walker A. M., Bennett D., Epidemiology and outcomes in patients with atrial fibrillation in the United States. Heart Rhythm 2008 5 10 1365 1372 2-s2.0-54549083168 10.1016/j.hrthm.2008.07.014
21. Granger C. B., Alexander J. H., McMurray J. J., Apixaban versus warfarin in patients with atrial fibrillation. The New England Journal of Medicine 2011 365 981 992 10.1056/NEJMoa1107039
22. Connolly S. J., Ezekowitz M. D., Yusuf S., Dabigatran versus warfarin in patients with atrial fibrillation. The New England Journal of Medicine 2009 361 1139 1151 10.1056/NEJMoa0905561
23. Patel M. R., Mahaffey K. W., Garg J., Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. The New England Journal of Medicine 2011 365 883 891 10.1056/NEJMoa1009638
24. Madden J. L., Resection of the left auricular appendix; a prophylaxis for recurrent. The Journal of the American Medical Association 1949 140 9 769 772 2-s2.0-78650999388
25. Weimar T., Schena S., Bailey M. S., The cox-maze procedure for lone atrial fibrillation: a single-center experience over 2 decades. Circulation: Arrhythmia and Electrophysiology 2012 5 8 14 10.1161/CIRCEP.111.963819
26. Dawson A. G., Asopa S., Dunning J., Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion? Interactive Cardiovascular and Thoracic Surgery 2010 10 2 306 311 2-s2.0-75449096636 10.1510/icvts.2009.227991
27. Bonow R. O., Carabello B. A., Chatterjee K., de Leon A. C., Faxon D. P., Freed M. D., Gaasch W. H., Lytle B. W., Nishimura R. A., O'Gara P. T., O'Rourke R. A., Otto C. M., Shah P. M., Shanewise J. S., 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): endorsed by the society of cardiovascular. Circulation 2008 118 15 e523 e661 2-s2.0-55249125191 10.1161/CIRCULATIONAHA.108.190748
28. Sievert H., Lesh M. D., Trepels T., Omran H., Bartorelli A., Bella P. D., Nakai T., Reisman M., DiMario C., Block P., Kramer P., Fleschenberg D., Krumsdorf U., Scherer D., Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 2002 105 16 1887 1889 2-s2.0-0037161359 10.1161/01.CIR.0000015698.54752.6D (Pubitemid 34437613)
29. Ostermayer S. H., Reisman M., Kramer P. H., Matthews R. V., Gray W. A., Block P. C., Omran H., Bartorelli A. L., Della Bella P., Di Mario C., Pappone C., Casale P. N., Moses J. W., Poppas A., Williams D. O., Meier B., Skanes A., Teirstein P. S., Lesh M. D., Nakai T., Bayard Y., Billinger K., Trepels T., Krumsdorf U., Sievert H., Percutaneous left atrial appendage transcatheter occlusion (PLAATO System) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. Journal of the American College of Cardiology 2005 46 1 9 14 2-s2.0-21344473932 10.1016/j.jacc.2005.03.042 (Pubitemid 40905122)
30. Block P. C., Burstein S., Casale P. N., Kramer P. H., Teirstein P., Williams D. O., Reisman M., Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for Warfarin therapy. 5-year results of the PLAATO (percutaneous left atrial appendage transcatheter occlusion) study. Journal of the American College of Cardiology: Cardiovascular Interventions 2009 2 7 594 600 2-s2.0-67650621409 10.1016/j.jcin.2009.05.005
31. Park J. W., Bethencourt A., Sievert H., Santoro G., Meier B., Walsh K., Lopez-Minquez J. R., Meerkin D., Valdés M., Ormerod O., Leithäuser B., Left atrial appendage closure with Amplatzer Cardiac Plug in atrial fibrillation: initial European experience. Catheterization and Cardiovascular Interventions 2011 77 5 700 706 2-s2.0-79953040948 10.1002/ccd.22764
32. Lam Y. Y., Yip G. W., Yu C. M., Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheterization and Cardiovascular Interventions 2012 79 5 794 800 10.1002/ccd.23136
33. Holmes D. R., Reddy V. Y., Turi Z. G., Doshi S. K., Sievert H., Buchbinder M., Mullin C. M., Sick P., Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. The Lancet 2009 374 9689 534 542 2-s2.0-68349151861 10.1016/S0140-6736(09)61343-X
34. Sick P. B., Schuler G., Hauptmann K. E., Grube E., Yakubov S., Turi Z. G., Mishkel G., Almany S., Holmes D. R., Initial worldwide experience with the watchman left atrial appendage system for stroke prevention in atrial fibrillation. Journal of the American College of Cardiology 2007 49 13 1490 1495 2-s2.0-33947587475 10.1016/j.jacc.2007.02.035 (Pubitemid 46505070)
35. Bayard Y. L., Ostermayer S. H., Sievert H., Transcatheter occlusion of the left atrial appendage for stroke prevention. Expert Review of Cardiovascular Therapy 2005 3 6 1003 1008 2-s2.0-28644446215 10.1586/14779072.3.6.1003 (Pubitemid 41748367)
36. Reddy V. Y., Holmes D., Doshi S. K., Neuzil P., Kar S., Safety of percutaneous left atrial appendage closure: results from the watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation 2011 123 4 417 424 2-s2.0-79751531253 10.1161/CIRCULATIONAHA.110.976449
37. Lee R. J., Bartus K., Yakubov S. J., Catheter-based left atrial appendage (LAA) ligation for the prevention of embolic events arising from the LAA initial experience in a canine model. Circulation: Cardiovascular Interventions 2010 3 3 224 229 2-s2.0-77955899530 10.1161/CIRCINTERVENTIONS.109.914978
38. Bartus K., Bednarek J., Myc J., Kapelak B., Sadowski J., Lelakowski J., Yakubov S. J., Lee R. J., Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm 2011 8 2 188 193 2-s2.0-79251568013 10.1016/j.hrthm.2010.10.040
39. Watson T., Shantsila E., Lip G. Y., Mechanisms of thrombogenesis in atrial fibrillation: virchow's triad revisited. The Lancet 2009 373 9658 155 166 2-s2.0-58149204184 10.1016/S0140-6736(09)60040-4